(Q35219334)

7 August 2017

1 reference

title

Against the self: dendritic cells versus cancer (English)

1 reference

7 August 2017

Hearn Jay Cho

1

1 reference

7 August 2017

Nina Bhardwaj

series ordinal

2

1 reference

7 August 2017

publication date

1 July 2003

1 reference

Acta Pathologica et Microbiologica Scandinavica

7 August 2017

published in

1 reference

7 August 2017

volume

111

1 reference

7 August 2017

issue

7-8

1 reference

7 August 2017

page(s)

805-817

1 reference

Suppression of lymphoma and epithelial malignancies effected by interferon gamma

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Evidence for tumor-specific immunity in human malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Dendritic cell-dead cell interactions: implications and relevance for immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Immunobiology of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Dendritic cells: specialized and regulated antigen processing machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Antigen presentation to CD8+ T cells: cross-priming in infectious diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Cytotoxic T lymphocyte activation by cross-priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Cross-presentation in viral immunity and self-tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Recycling MHC class I molecules and endosomal peptide loading

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Phagocytic processing of bacterial antigens for class I MHC presentation to T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Costimulation, tolerance and ignorance of cytolytic T lymphocytes in immune responses to tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Antitumor monoclonal antibodies enhance cross-presentation ofcCellular antigens and the generation of myeloma-specific killer T cells by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Dendritic cells acquire antigens from live cells for cross-presentation to CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

4-1BB-specific monoclonal antibody promotes the generation of tumor-specific immune responses by direct activation of CD8 T cells in a CD40-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

T-cell co-stimulation through B7RP-1 and ICOS

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Stimulatory effects of B7-related protein-1 on cellular and humoral immune responses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

B7H costimulates clonal expansion of, and cognate destruction of tumor cells by, CD8(+) T lymphocytes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Complementary dendritic cell-activating function of CD8+ and CD4+ T cells: helper role of CD8+ T cells in the development of T helper type 1 responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Induction of antigen-specific human CD4(+) T cell anergy by peripheral blood DC2 precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Enhanced susceptibility to cytotoxic T lymphocytes without increase of MHC class I antigen expression after conditional overexpression of heat shock protein 70 in target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Proinflammatory cytokines and CD40 ligand enhance cross-presentation and cross-priming capability of human dendritic cells internalizing apoptotic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Rat spleen dendritic cells express natural killer cell receptor protein 1 (NKR-P1) and have cytotoxic activity to select targets via a Ca2+-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

BCL-2 family: regulators of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Type I interferon is required to mount an adaptive response to immunostimulatory DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Cutting Edge: Intravenous Soluble Antigen Is Presented to CD4 T Cells by CD8- Dendritic Cells, but Cross-Presented to CD8 T Cells by CD8+ Dendritic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Improved efficacy of dendritic cell vaccines and successful immunization with tumor antigen peptide-pulsed peripheral blood mononuclear cells by coadministration of recombinant murine interleukin-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Antiviral immune responses of mice lacking MHC class II or its associated invariant chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Engagement of the OX-40 receptor in vivo enhances antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Transforming growth factor-beta produced by progressor tumors inhibits, while IL-10 produced by regressor tumors enhances, Langerhans cell migration from skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

The role of heat shock protein (hsp70) in dendritic cell maturation: hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Noncovalent association with stress protein facilitates cross-priming of CD8+ T cells to tumor cell antigens by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Defective CD4T cell priming and resistance to experimental autoimmune encephalomyelitis in TNF-deficient mice due to innate immune hypo-responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Inhibition of CD40 expression and CD40-mediated dendritic cell function by tumor-derived IL-10

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Dendritic cells for NK/LAK activation: rationale for multicellular immunotherapy in neuroblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytes choriomeningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

7 January 2021

Restriction by H-2 gene complex of transfer of cell-mediated immunity to Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

7 January 2021

Decreased tumor surveillance in perforin-deficient mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

7 January 2021

Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

7 January 2021

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

7 January 2021

A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

7 January 2021

Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

7 January 2021

Three-cell-type clusters of T cells with antigen-presenting cells best explain the epitope linkage and noncognate requirements of the in vivo cytolytic response

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

7 January 2021

Proinflammatory and immunoregulatory functions of interleukin-12.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

7 January 2021

Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

7 January 2021

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

7 January 2021

Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

7 January 2021

The critical role of interleukin-6, interleukin-1B and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

7 January 2021

Partial purification and characterization of a vascular permeability factor secreted by a human colon adenocarcinoma cell line.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

7 January 2021

A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

7 January 2021

Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0463.2003.11107812.X

7 January 2021

10.1034/J.1600-0463.2003.11107812.X

Identifiers

DOI

1 reference

7 August 2017

1 reference